Wikidata:WikiProject COVID-19/Statements/Q84082454
Predefinitions edit
?authors author (P50) Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV (Q84082454)
Title edit
Abstract edit
Coronavirus (Q57751738) has effect (P1542) respiratory disease (Q3286546) Coronavirus (Q57751738) first identified in wet market (Q842153)
?authors developed screening (technique (Q2695280))
SARSr-CoV (Q278567) parent taxon (P171)* Lineage B Betacoronavirus (Q16532287)
SARS-CoV-2 (Q82069695) parent taxon (P171)* Lineage B Betacoronavirus (Q16532287)
?authors developed screening (technique (Q2695280)) to identify viral receptor (Q88024575) of Lineage B Betacoronavirus (Q16532287)
?authors developed screening (technique (Q2695280)) to identify target cell type (Q189118) of Lineage B Betacoronavirus (Q16532287)
peptidase activity (Q14645703) inhibits viral entry into host cell (Q4118894) of Lineage B Betacoronavirus (Q16532287).
If that does not happen, then Lineage B Betacoronavirus (Q16532287) infects human cell (Q75402508).
SARS-CoV-2 (Q82069695) entry receptor is angiotensin I converting enzyme 2 (Q301630)